Um dos principais objetivos do Life4me+ - é prevenir novos casos de HIV e outras ISTs, hepatite C e tuberculose.

O aplicativo ajuda a estabelecer uma comunicação anônima entre médicos e pessoas soropositivas. A App permite que você organize convenientemente o seu horário de toma dos medicamentos e defina de uma forma personalizada os lembretes.

Todas as notícias

Arquivo

✕

9 fevereiro 2018

5127

HIV prevention drug Truvada to be publicly funded in New Zealand

HIV prevention drug Truvada to be publicly funded in New Zealand

Pharmac estimates up to 4,000 people with a high risk of contracting HIV will be eligible for a drug to prevent infection with the virus which the Government's drug buying agency will now fund. New Zealand will be one of the first countries in the world to publicly fund ...

9 fevereiro 2018

4981

Kenneth Cole Steps Down as amfAR Chairman

Kenneth Cole Steps Down as amfAR Chairman

Kenneth Cole is stepping down as amfAR chairman, the designer announced Wednesday night at the charity's annual gala in New York.

9 fevereiro 2018

5181

Ukraine Expands Opioid Substitution Therapy to Reduce HIV

Ukraine Expands Opioid Substitution Therapy to Reduce HIV

The Ukrainian government is increasing the scope of the country’s state-funded opioid substitution therapy programme – a harm reduction tool which reduces the risk of overdose and disease transmission.

8 fevereiro 2018

4921

Scientists report big improvements in HIV vaccine production

Scientists report big improvements in HIV vaccine production

Technical advances in vaccine production should shorten the time to clinical trials, breaking the logjam of promising new candidate vaccines waiting to be tested.

8 fevereiro 2018

7460

FDA Approves Gilead’s Biktarvy for Treatment of HIV

FDA Approves Gilead’s Biktarvy for Treatment of HIV

Food and Drug Administration has approved Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg, BIC/FTC/TAF), a once-daily single tablet regimen for the treatment of HIV-1 infection.

7 fevereiro 2018

4781

New data helps prioritise groups for HIV treatment

New data helps prioritise groups for HIV treatment

People aged 50 or over, individuals with low CD4 to CD8 ratios, and those with high viral loads are the groups that benefit the most from immediate antiretroviral treatment.

7 fevereiro 2018

5412

New insight into how some viruses establish a chronic infection

New insight into how some viruses establish a chronic infection

The previously undiscovered molecular mechanism explains how certain viruses, including HIV and hepatitis C, can actively make immune cells less functional, allowing an infection to spread ahead of the body's immune response.

6 fevereiro 2018

7828

Persian shallot could help fight TB antibiotic resistance

Persian shallot could help fight TB antibiotic resistance

A type of onion could help the fight against antibiotic resistance in cases of tuberculosis, a study has suggested.

6 fevereiro 2018

8323

Mobile app for free condoms launched in the Philippines

Mobile app for free condoms launched in the Philippines

To tackle low condom use, activists have teamed up with restaurants and shops to set up dispensers with free condoms in the capital Manila which users can locate through an app.

5 fevereiro 2018

5575

Mortality in HIV-Infected Children Predicted by Urine TB Lipoarabinomannan

Mortality in HIV-Infected Children Predicted by Urine TB Lipoarabinomannan

According to the study authors, HIV-infected hospitalized children initiating antiretroviral therapy are part of “a group in which tuberculosis diagnosis is often missed, and in whom early tuberculosis treatment is lifesaving.”

1...43 44 45 46 47...117